Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2026-03-05 @ 12:07 AM
Study NCT ID:
NCT01650194
Status:
COMPLETED
Last Update Posted:
2024-12-10
First Post:
2012-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
Sponsor:
Astellas Pharma Global Development, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-24
First Submit QC Date:
None
Study First Post Date:
2012-07-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-13
Results First Submit QC Date:
None
Results First Post Date:
2019-02-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-18
Last Update Post Date:
2024-12-10
Last Update Post Date Type:
ACTUAL